Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of CITUS Dry Syrup in children with perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• CITUS Dry Syrup

Snippet

Sponsor: SamA Pharmaceutical Co., Ltd | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED